Integrichain Blog

Blog

Pharmaceutical team discussing the future of the pharmaceutical industry

Contracts & Pricing Tim Murdoch
November 4, 2024

Why I Chose IntegriChain: A Journey from Tech Giants to Transforming...

2 Minute Read

Read the latest blog from our CCO Tim Murdoch, Why I Chose IntegriChain: A Journey from Tech Giants to Transforming Pharma Commercialization.

Medicare Part D Changes

Contracts & Pricing Ben Fanelli Michael Gorokhovsky
October 31, 2024

Industry Shifts: A Closer Look at Recent CMS and J&J Announcements

3 Minute Read

Read the latest on the CMS September Final Rule Overview & a Controversial 340B Rebate Policy

Rectangle 840x200v1

Contracts & Pricing Katie Herrick Dan Landis
September 4, 2024

Understanding the $35 Patient Out-of-Pocket Strategy: Implications for Pharmaceutical Manufacturers

2 Minute Read

Katie Herrick and Dan Landis, consultants from Blue Fin Group, discuss how pharmaceutical companies are adapting to the changing healthcare environment by focusing on improving patient access and affordability.

changes in pharmaceutical pricing regulations

Contracts & Pricing Nick Lynch
September 4, 2024

Key Developments in Pharmaceutical Pricing Regulations

4 Minute Read

Nick Lynch, Partner of Federal Compliance Solutions (FCS) discusses insights into recent developments in pharmaceutical pricing, focusing on government programs like 340B, Medicaid Drug Rebate Program (MDRP), Medicare Part...

IRA’s Impact on Medicare Part D Expenditures

Contracts & Pricing Jeff Baab
June 12, 2024

The Wild Ride of Medicare Part D Payer Challenges on Expenditures...

3 Minute Read

Learn about the IRA's changes to Part D benefits have created uncertainty for both manufacturers and payers.

April Pharmaceutical Industry Market Update

Contracts & Pricing Sarah Vo Brian Bumpus Rupal Patel
April 24, 2024

Changing Pharmacy Reimbursements with CVS, FSS/IFF Reporting Alert & the Latest...

3 Minute Read

Discover the latest on the Pharmacy Reimbursements for CVS, FSS/IFF Reporting Alert, and the 340B Drug Discount Program.

Illinois Pharma Price Gouging Law Challenged

Contracts & Pricing Jui Andhare Jordan Boruff Olivia Nweze
March 21, 2024

FDA Approves Florida Drug Imports from Canada, GLP-1 Market Dilemma, &...

5 Minute Read

Discover the latest on the FDA Approving Florida's Plan to Import Prescription Drugs from Canada, The GLP-1 Market Dilemma, and Illinois Price Gouging Law updates this month.

Medicare Part D Agreement & WAC Drug Pricing Changes

Contracts & Pricing Ben Fanelli Nick Iaconi Jeff Baab Olivia Nweze
January 31, 2024

The New Medicare Part D Agreement, AMP Removals Impact on WAC...

9 Minute Read

Discover the latest on the New Medicare Part D Agreement, 2024 Pharma Industry Shake-Up andth 2023 SPTR Recap updates this month.

Medicare Part D Changes

Contracts & Pricing Jyotika Arora Ben Fanelli Rupal Patel
December 21, 2023

Medicare Part D Changes, IRA Guidance, & 340B Updates

4 Minute Read

Discover the latest on Medicare Part D, IRA Guidance, and 340B updates this month.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article